NIH-funded research NIH-funded research

Transformative protein-misfolding blood test for heart disease

Official title: A Transformative Structural Proteomics Platform for Early Detection of Misfolding-Driven Cardiovascular Diseases

Funded at 3d Bioanalytix, INC. · NIH-11358636 · Data updated 2026-11-12

A blood test called Amyfold, based on a new protein-mapping method, could help doctors catch early misfolding-related heart diseases in people at risk.

More Cardiovascular Diseases research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institution3d Bioanalytix, INC.
NIH-funded
Lab location1 site (San Diego, United States)
Project startJuly 1, 2026
Project endApril 30, 2028
Funding year2026
Award (this year)$421,400
NIH project number1R33HL185603-01
Project IDNIH-11358636 on NIH RePORTER

Who could benefit from this research

Could help

Adults who are at risk for or suspected to have transthyretin amyloid cardiomyopathy or related amyloid-related cardiovascular conditions, and who can provide blood samples for testing.

Less likely to help

People without suspected misfolding-related cardiovascular disease or no access to blood sampling may not benefit.

What this research studies

This project adapts a cutting-edge protein-mapping platform to blood samples to detect misfolded proteins linked to heart disease. It focuses on creating a first‑in‑class blood test for transthyretin amyloid cardiomyopathy and related conditions, using mass spectrometry to measure protein shape changes directly in plasma. By validating performance and preparing for clinical use, it aims to speed accurate diagnosis and enable timely treatment for patients with or at risk for amyloid-related heart disease.

Why it matters

Potential benefit: If successful, Amyfold could enable earlier, less invasive diagnosis and better monitoring, potentially slowing or preventing progression of misfolding-related heart disease.

How similar studies have gone: Preliminary pilot studies showed high sensitivity and specificity in detecting misfolded proteins, supporting continued development.

Where this research is happening

  • 3d Bioanalytix, INC.
    San Diego, United States
    Active

Researchers

  • Principal investigator: Pankow, Sandra — 3d Bioanalytix, INC.
  • Study coordinator: Pankow, Sandra

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.